SCHEMBL4877146

SCHEMBL4877146

COc1ccc(-c2n[nH]cc2Oc2ccc(F)cc2)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.47
CYP1B1 Q16678 3/20 0.47
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HPGD P15428 1/20 0.42
MAPK8 P45983 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2E1 P05181 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2A6 P11509 1/20 0.41
CYP4B1 P13584 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP3A5 P20815 1/20 0.41
CYP2A7 P20853 1/20 0.41
CYP3A7 P24462 1/20 0.41
CYP2F1 P24903 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884599 0.88 KMT2A (0.49) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL14197358 0.88 CYP1A1 (0.45) CYP1A1CYP1B1ALDH1A1KDM4EHPGD
SCHEMBL17714196 0.86 MEN1 (0.43) CYP1A1CYP1B1ALDH1A1KDM4EHPGD
SCHEMBL4873495 0.81 CYP1A1 (0.47) CYP1A1CYP1B1ALDH1A1KDM4EHPGD
SCHEMBL4876502 0.81 CYP1A2 (0.41) CYP1A1CYP1B1ALDH1A1KDM4EHPGD
SCHEMBL4877768 0.77 MEN1 (0.45) ALDH1A1HPGDMAPK8HTTGAA
SCHEMBL4873458 0.77 MAPT (0.45) KDM4EHPGDCYP1A2CYP3A4CYP2D6
SCHEMBL4876579 0.76 MAPT (0.52) ALDH1A1KDM4EHPGDHTTGAA
SCHEMBL4881463 0.75 MEN1 (0.56) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL4880281 0.74 MEN1 (0.50) ALDH1A1KDM4EHPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795120-B Novel pyridyloxy-and phenyloxy-pyrazolyl compounds 豪夫迈·罗氏有限公司 2020-09-01 CN claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP disclosed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P CYP1A1 562/4885CYP1B1 747/4885ALDH1A1 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.